Thirteen fetuses (five twin, one triplet) were compromised by fetofetal transfusion syndrome in six pregnancies, five in the mid trimester, and one in the third trimester. This diagnosis, which was suspected because of ultrasound findings of discordant growth, discordant amniotic fluid volumes, concordant external genitalia, and monochorial placentation, was confirmed postnatally in each. Nine fetuses underwent blood sampling to aid diagnosis and assessment of fetal welibeing. In contrast to fetofetal transfusion syndrome investigated postnatalHy, a difference in haemoglobin concentration of 50 g/l or more in utero was found in only one pregnancy, which was near term, although ali had fetal erythroblastaemia and a difference in weight of 20% or more. In vivo confirmation of shared circulation was achieved in two pregnancies by transfusing adult Rh negative red celis into the smaller fetus and then detecting them by Kleihauer testing in blood aspirated from the larger. Invasive procedures also yielded information on fetal blood gas measurements (acidaemia in four and hypoxaemia in six) and amniotic pressure (raised in two). We suggest that comparison of haemoglobin concentrations is inaccurate in fetofetal transfusion syndrome in utero, the diagnosis of which may necessitate detection of a shared circulation using a marker such as adult red celHs.
diagnosis, which was suspected because of ultrasound findings of discordant growth, discordant amniotic fluid volumes, concordant external genitalia, and monochorial placentation, was confirmed postnatally in each. Nine fetuses underwent blood sampling to aid diagnosis and assessment of fetal welibeing. In contrast to fetofetal transfusion syndrome investigated postnatalHy, a difference in haemoglobin concentration of 50 g/l or more in utero was found in only one pregnancy, which was near term, although ali had fetal erythroblastaemia and a difference in weight of 20% or more. In vivo confirmation of shared circulation was achieved in two pregnancies by transfusing adult Rh negative red celis into the smaller fetus and then detecting them by Kleihauer testing in blood aspirated from the larger. Invasive procedures also yielded information on fetal blood gas measurements (acidaemia in four and hypoxaemia in six) and amniotic pressure (raised in two). We Although vascular communications are found in the placentas of almost all monochorial twin pregnancies, clinical signs of twin to twin transfusion occur in only 4-26%.' 2 The pathophysiology of this condition, known as fetofetal transfusion syndrome, is poorly understood. In general however, the donor twin becomes anaemic, growth is retarded, and it develops oligohydramnios, whereas the recipient develops hydrops, cardiomegaly, and polyhydramnios. 3 Most reported cases have been diagnosed postnatally or at necropsy. The standard neonatal criteria comprise a difference in cord haemoglobin concentrations of 50 g/l or more, and a difference in birth weights of 20% or more,4-6 although the latter criterion is not necessarily present in the acute form of fetofetal transfusion syndrome that occurs in labour.7 Certain antenatal ultrasound appearances are highly suggestive of fetofetal transfusion syndrome,> " 1 principally discrepant growth, and amniotic fluid volumes between monochorionic diamnionic twins.8 iOu 1 Discordant growth, however, is a common complication of twin pregnancies, and causes other than fetofetal transfusion syndrome exist for discordant amniotic fluid volume. Signs of hydrops fetalis on ultrasound scan are occasionally found in the recipient,o1 11 rarely in the donor,4 and exceptionally in both.'2 As all the above ultrasound features are non-specific, more accurate methods of antenatal diagnosis are needed if its associated high perinatal mortality rate of 40-81% is to be reduced.8'0 13 Pregnancies complicated by fetofetal transfusion syndrome will increasingly be evaluated in utero now that some of its signs-for example, intrauterine growth retardation, hydrops, and abnormal amniotic fluid volume, have become accepted indications for fetal blood sampling. Although precise criteria exist for the postnatal diagnosis of fetofetal transfusion syndrome, none have as yet been defined for its diagnosis in utero. We describe our experience of detailed fetal assessment in fetofetal transfusion syndrome using ultrasound scanning and fetal blood sampling.
Patients and methods Among multiple pregnancies referred over a three year period for investigation of discordant fetal growth, the diagnosis of fetofetal transfusion syndrome was strongly suspected in six (five twin, one triplet) because of ultrasonographic findings of discrepant amniotic fluid volume, concordant external genitalia, and a monochorionic placenta, in addition to discordant intrauterine growth retardation. Gestational ages ranged from 17-36 weeks, with only one patient beyond 27 weeks.
Initial assessment comprised detailed ultrasound scanning, examining in particular the site of the placenta, the thickness of the septum,'4 the depth of the amniotic fluid pools, and the presence of hydrops. In four cases, pulsed Doppler studies of umbilical arterial flow velocity waveforms were undertaken (Acuson, Mountain View, California, USA). The indications for fetal blood sampling were the investigation (karyotype and blood gas analysis) of severe intrauterine growth retardation in six, of hydrops in three, and of polyhydramnios in four, and the exclusion of coagulopathy in one twin after the intrauterine death of its monochorial sibling two to three weeks before.9 15 16 Additional reasons for fetal blood sampling were in all cases to assess fetal wellbeing and to attempt to confirm the diagnosis by detecting differences in haemoglobin concentrations. All patients gave written informed consent. Fetal blood sampling was carried out with a 20 gauge needle inserted under ultrasound guidance. The site of sampling was the placental cord insertion in five, the intrahepatic vein in one, and a free loop of cord in three. Gross polyhydramnios precluded fetal blood sampling in the other fetus(es) in cases 3 and 6.
The purity and fetal source of samples was checked at the time by separate red cell volume distributions on a particle size analyser (Coulter Channelyzer C-256, Coulter Electronics) and later confirmed by the Kleihauer test.'7 The packed cell volume and haemoglobin concentration in fetal blood were determined by a Coulter S Plus Counter. Nucleated red cells and reticulocyte counts were calculated from ratios obtained from blood films, which in turn were applied to results from the automated cell counter as described previously.'8 Blood gas analysis was performed on 250 ,ul of fetal blood collected into heparinised capillary tubes. 9 Published normal ranges were used for haemoglobin,20 packed cell volume,2' erythroblasts,22 and blood gases.23 Karyotypes were determined in fetal blood after short term fibroblast culture.
To document the presence of placental vascular anastomoses in vivo, adult blood (group 0 Rh negative and seronegative for cytomegalovirus was transfused into two donor fetuses. Fetal blood samples were then taken from their presumed recipient sibling to determine, using the Kleihauer technique, the passage of transfused adult red cells from one twin to the other.
The needle used for taking the sample of fetal blood was also used to provide access to the amniotic cavity. Four patients with gross polyhydramnios underwent therapeutic drainage of amniotic fluid to reduce amniotic pressure.24 25 Amnioinfusion was carried out in one fetus to allow a thin septum to be seen; it had previously not been visible, but was suspected because of fetal immobility. '4 Necropsy was performed by one of two perinatal pathologists in all but one case of fetal loss, in which consent was withheld. Postpartum evaluation of the configuration of placental membranes confirmed monochorionic diamniotic or triamniotic placentas in all. Meticulous injection studies were not performed, although shared areas on the chorionic surface were evaluated macroscopically. Pathological extramedullary haemopoiesis was defined as histological evidence of increased hepatic haemopoiesis out of proportion to that seen in normal fetuses of similar gestational age.
For reasons of clarity, sibling fetuses are denoted by the letters A to C, with the recipient fetus in each pregnancy referred to as fetus A. Six and 18 ml of donor blood (packed cell volumes of 0-72 and 0-87) were transfused into the donor twins of cases 4 and 5, respectively. Kleihauer testing of fetal blood then obtained from the recipient twins 25 minutes (case 4) and 16 minutes (case 5) later showed that 145 and 70 cells/1000, respectively, had stained as adult cells. In both cases the needle tip was seen clearly within the umbilical vein of the recipient suggesting that appreciable maternal contamination was unlikely. This procedure was carried out in case 4 to document the sharing of circulations in utero, in view of the similar fetal haemoglobin concentrations. In contrast, this was done in case 5 at 36 weeks to improve the condition of the fetus before delivery by correcting polycythaemia and anaemia. In case 5 the recipient was sampled first, polycythaemia was confirmed, and 30 ml of blood was with- There were 11 fetal or perinatal losses, giving a total perinatally related wastage of 85%.
Results
The diagnostic criteria by which all these pregnancies were considered to have been complicated by fetofetal transfusion syndrome are shown in table 3. Discordant growth and amniotic fluid volumes in the presence of monochorionic placentas was seen on ultrasonography in all, and hydrops was noted in three recipient fetuses. After delivery, fetofetal transfusion syndrome was confirmed in each by differences in fetal weight of 20% or more. In the four that underwent necropsy, extramedullary haemopoiesis in the donor, with or without relative macrocardia in the recipient, provided additional confirmation of the diagnosis.26 In the remaining two, additional confirmation was achieved by the difference in haemoglobin concentrations (case 5), and the clinical appearance at delivery (case 3).3 Discussion Fetal haematology in these pregnancies with fetofetal transfusion syndrome suggests that, unlike postnatally, a haemoglobin difference of 50 g/l or more is not necessarily found in utero. In this series, only one of three twin pregnancies in which both fetuses were sampled showed major differences in haemoglobin values (case 5), and this was in a pregnancy with a chronic well compensated fetofetal transfusion syndrome sampled late in the third trimester. In contrast, the remaining two without major differences in haemoglobin concentrations were at much earlier gestations (21 and 23 weeks). Case 1 showed a degree of polycythaemia in both fetuses, while in case 4, polycythaemia was found in the donor and not in the recipient. In this atypical case, however, a marginal velamentous cord insertion with abnormal umbilical Doppler flow implicated deficient placentation in the donor's intrauterine growth retardation, itself a known cause for polycythaemia. In the two multiple pregnancies in which only the recipient was sampled, raised haemoglobin concentrations and packed cell volumes were consistent with the diagnosis of fetofetal transfusion syndrome. Because of the above discrepancies, and the existence of other mechanisms for polycythaemia, however, isolated polycythaemia in one twin or triplet cannot be considered diagnostic.
Rausen et al were the first to suggest that a An alternative approach to diagnosis is in vivo demonstration of appreciable sharing of circulations. This was achieved in two pregnancies by giving a readily detectable safe marker with subsequent demonstration of its passage in substantial quantities into the recipient. The finding of a considerable proportion of adult red cells in the recipients (14-5 and 7% of red cells in cases 4 and 5, respectively) after only short intervals suggests that a large amount of transfer occurred rapidly. We found no such transfer in an Rh alloimmunised monochorionic twin pregnancy uncomplicated by fetofetal transfusion syndrome in whom intrauterine transfusion was indicated for fetal anaemia, but this is anecdotal evidence and the technique warrants further evaluation in the diagnosis of fetofetal transfusion syndrome in utero.
Fetal blood sampling in this series supplied additional information about fetal wellbeing. Four of nine fetuses were acidaemic, while two others in addition to these four were also hypoxaemic. As with other high risk pregnancies, fetal acid base balance may contribute to the assessment of fetal compromise and to the timing of intervention or delivery, or both.
This series confirms the extremely high mortality (85%) in fetofetal transfusion syndrome,'3 30 and reflects both the severity of disease and the early gestation of the patients referred. All fetal losses in this series occurred before 28 
